Menformon A en es it fr

Menformon A Brand names, Menformon A Analogs

Menformon A Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Menformon A Chemical_Formula


Menformon A RX_link

No information avaliable

Menformon A fda sheet

Menformon A msds (material safety sheet)

Menformon_A MSDS

Menformon A Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Menformon A Molecular Weight

270.366 g/mol

Menformon A Melting Point

254.5-256 oC

Menformon A H2O Solubility

3 g/100mL

Menformon A State


Menformon A LogP


Menformon A Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Menformon A Indication

For management of Menopausal and postmenopausal disorders

Menformon A Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Menformon A Absorption


Menformon A side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Menformon A Patient Information

Menformon A Organisms Affected

Humans and other mammals